Loading...
Thumbnail Image
Publication

Corrigendum to “Evolving strategies and application of proteins and peptides therapeutics in cancer treatment” [Biomed. Pharmacother. 163 (2023) 114832]

Abstract
This Corrigendum relates to the above article. In this article, the authors have included Refs. [85,137,310] that require correction due to contextual inappropriateness: [85] F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: a Cancer J. Clin. 68 (6) (2018) 394–424, https://doi.org/10.3322/caac.21492. [137] H. L¨aubli, A. Varki, Sialic acid–binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses, Cell. Mol. Life Sci. 77 (4) (2020) 593–605, https://doi.org/10.15212/bioi-2020–0013. [310] M.R. Mirza, B.J. Monk, J. Herrstedt, A.M. Oza, S. Mahner, A. Redondo, I. Vergote, Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer, N. Engl. J. Med. 375 (22) (2016) 2154–2164, https://doi.org/10.1056/NEJMoa1611310. The authors confirm that these references were inadvertently introduced in the article. Refs. [85,137,310] should be considered as removed from the reference list and their intext citations ignored. The authors apologize for this oversight.